In contrast, significantly enriched terms for the NAT group (CPTAC dataset) combined both physiological ones similar to the HA-RT group and the cancer-associated ones, including K-ras signaling, epithelial-mesenchymal transition (EMT) and complement activation (Fig. 4B). The gene discussed is BRD2; the disease is cancer.